Table 1 Patient and tumor characteristics
From: Clinical outcomes and toxicity of proton beam therapy for advanced cholangiocarcinoma
N or range | % or median | |
|---|---|---|
No. of patients | 28 | 100 |
Age (years) | 48–89 | 78 |
Sex | ||
Male | 17 | 61 |
Female | 11 | 39 |
Tumor size, maximum diameter (mm) | 20–175 | 52 |
ECOG* performance status | ||
0 | 15 | 54 |
1 | 8 | 29 |
2 | 5 | 18 |
Tumor location | ||
Intrahepatic | 6 | 21 |
Extrahepatic | - | - |
Hilar | 6 | 21 |
Distal | 3 | 11 |
Gall bladder | 3 | 11 |
Tumor recurrence after surgery | ||
Local | 7 | 25 |
Nodal | 3 | 11 |
CA19-9† | ||
<37 | 13 | 46 |
≥37 | 15 | 54 |
Palliative stent placement | ||
No | 20 | 71 |
Yes | 8 | 29 |